Brief: Theseus Pharmaceuticals Shares Open 30% Above IPO Price In Nasdaq Debut
07/10/2021 16:41
Oct 7 (Reuters) -
* THESEUS PHARMACEUTICALS SHARES OPEN AT $20.80 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $16.00/SHARE
Further company coverage: THRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7